BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The T-cell engager field is advancing faster than ever. With m
 ultiple clinical approvals validating the staying power of this modality\
 , and a new wave of next-generation solid tumor and autoimmune programs m
 oving rapidly towards the clinic\, the momentum behind T-Cell engagers ha
 s never been stronger. These therapies are increasingly cited as one of t
 he most promising drivers of the next era of immunotherapy.\n\nOver the p
 ast year\, the sector has experienced a surge of investment\, deal-making
  and strategic collaboration. Landmark partnerships such as BMS x JanuX T
 herapeutics\, Candid Therapeutics x WuXi Biologics and AbbVie x EvolveImm
 une signal growing confidence in the transformative potential of immune-r
 edirecting platforms and reinforce commitment to advancing TCE innovation
  across oncology and autoimmune disease.\n\nMoving from Boston to San Die
 go for 2026\, the 8th T-Cell Engager Therapeutics Summit stands as the in
 dustry's most comprehensive end-to-end meeting dedicated to advancing\, o
 ptimizing and translating T-cell engagers.\n\nThis case-study driven foru
 m is designed to equip engineering\, discovery\, R and D\, translational 
 and clinical development teams with the actionable insights needed to eng
 ineer safer\, more potent\, durable and precisely targets TCEs for solid 
 tumors\, while also spotlighting the breakthroughs extending engager biol
 ogy into autoimmune and inflammatory diseases.\n\nIf accelerating your TC
 E pipeline is a priority\, this is a meeting you cannot afford to miss.\n
 \nURLs:Website: https://go.evvnt.com/3501952-0?pid=185Tickets: https://go
 .evvnt.com/3501952-2?pid=185Brochure: https://go.evvnt.com/3501952-3?pid=
 185\n\nPrices:Conference + Workshop Day - Drug Developer Pricing: USD 439
 7.00\,Conference Only - Drug Developer Pricing: USD 3099.00\,Conference +
  Workshop Day - Academic Pricing: USD 3797.00\,Conference Only - Academic
  Pricing: USD 2699.00\,Conference + Workshop Day - Service Provider Prici
 ng: USD 5297.00\,Conference Only - Service Provider Pricing: USD 3799.00\
 n\nSpeakers: Ran You Principal Scienitst Amgen\, Saso Cemerski Executive 
 Director\, Head of Immune Engagers AstraZeneca\, Jonah Rainey Associate V
 ice President Eli Lilly and Co.\, Nicole Schirle Oakdale Principal Scient
 ist Gilead Sciences\, Mehabaw Derebe Principal Scientist Merck and Co\, A
 lison Crawford Director - Immuno Oncology Regeneron Pharmaceuticals\, Ves
 na Kramar Senior Scientist Roche\, Barbara Sennino Senior Vice President 
 and Head of Early Development 3T Biosciences\, Alex Martinko Senior Direc
 tor - Antibody Engineering and Design Cartography Biosciences\, Inc\, Mik
 e Maloney Director - Immunology Clasp Therapeutics\, Jack Silberstein CEO
  and Founder Deck Bio\, Martin Preyer Executive Director - Biotherapeutic
 s EvolveImmune Therapeutics\, Michael Dyson Vice President - Antibody Dis
 covery and Engineering Ichnos Glenmark Innovation\, Lawrence Lamb Executi
 ve Vice President and Chief Scientific Officer IN8Bio\, Suzette Girgis Vi
 ce President and Head of Global Clinical Pharmacology and Pharmacometrics
  Jazz Pharmaceuticals\, Daniel Foxler Cell Biology and Assay Development 
 Head LabGenius\, Xavier Parot Senior Medical Director ModeX Therapeutics\
 , Lauren Pitt Preclinical Development Head MyrioTx\, Surge Biswas Co-Foun
 der and Chief Executive Officer Nabla Bio\, Shihao chen Co-Founder QLSF B
 iotherapeutics\, Udaya Rangaswamy Senior Director - Translational Biology
  Rondo Therapeutics\, Rachel Rennard Senior Vice President - Research Ste
 reo Biotherapeutics\, Nathaniel Davies Senior Director Computational Biol
 ogy T-Cypher Bio\, Martin Pflügler Chief Executive Officer and Founder Tw
 yce Therapeutics\, Jennifer Towne Chief Scientific Officer and Executive 
 Vice President Vir Biotechnology\, Kendra Avery Director Xencor\, Genevie
 ve Desjardins Principal Scientist - Protein Engineering Zymeworks\n\nCate
 gory: Conferences | Science\, Health and Medicine | Pharmaceuticals\n\nDa
 te and Time: 23rd June 2026 at 7:30 am to 25th June 2026 at 5:30 pm\n\nVe
 nue details: The Westin San Diego Bayview\, 1051 Columbia Street\, San Di
 ego\, California\, 92101\, United States\n
DTEND:20260625T173000
DTSTAMP:20260512T214301Z
DTSTART:20260623T073000
LOCATION:The Westin San Diego Bayview\, 1051\, Columbia Street\, San Diego
 \, California\, 92101\,
SEQUENCE:0
SUMMARY:The T-cell engager field is advancing faster than ever. With multi
 ple clinical approvals validating the staying power of this modality\, an
 d a new w...
UID:fd2cc361-fdf3-4401-9867-a21573547ae8
END:VEVENT
END:VCALENDAR